Circular RNAs in Non-Small Cell Lung Cancer: Potential Biomarkers
Author Information
Author(s): Pedraz-Valdunciel Carlos, Rosell Rafael
Primary Institution: Germans Trias i Pujol Research Institute and Hospital
Hypothesis
Can circular RNAs serve as effective biomarkers for early detection and treatment response in non-small cell lung cancer?
Conclusion
Circular RNAs have significant potential as biomarkers for early detection and monitoring of treatment response in non-small cell lung cancer.
Supporting Evidence
- Circular RNAs are stable and can be found in blood, making them good candidates for biomarkers.
- Studies show that circular RNAs can help detect lung cancer and monitor treatment responses.
- Research indicates that circular RNAs are involved in cancer progression and treatment resistance.
Takeaway
Scientists are studying special types of RNA called circular RNAs to see if they can help find lung cancer early and understand how well treatments are working.
Methodology
This review analyzes the biology and current research on circular RNAs in non-small cell lung cancer, focusing on their potential as biomarkers and the methodologies used to study them.
Limitations
Current research is primarily focused on expression analysis in tumor samples, with limited validation in liquid biopsy specimens.
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website